Meghan Bliss-Moreau

Director, Analytical Development at SOTIO a.s. - Boston, MA, US

Meghan Bliss-Moreau's Contact Details
HQ
N/A
Location
San Diego,California,United States
Company
SOTIO a.s.
Meghan Bliss-Moreau's Company Details
SOTIO a.s. logo, SOTIO a.s. contact details

SOTIO a.s.

Boston, MA, US • 250 - 499 Employees
BioTech/Drugs

SOTIO Biotech is shaping the future of cancer immunotherapies by translating compelling science into patient benefit. SOTIO's robust clinical pipeline includes a differentiated superagonist of the attractive immuno-oncology target IL-15, a proprietary technology designed to improve on the efficacy of CAR T therapies and a new generation of potent and stable antibody-drug conjugates (ADCs). SOTIO is a member of the PPF Group.

N/A
Details about SOTIO a.s.
Frequently Asked Questions about Meghan Bliss-Moreau
Meghan Bliss-Moreau currently works for SOTIO Biotech.
Meghan Bliss-Moreau's role at SOTIO Biotech is Director, Analytical Development.
Meghan Bliss-Moreau's email address is ***@sotio.com. To view Meghan Bliss-Moreau's full email address, please signup to ConnectPlex.
Meghan Bliss-Moreau works in the Research industry.
Meghan Bliss-Moreau's colleagues at SOTIO a.s. are Zuzana Antosova, Olga Klopotowska, Christian Frantz, Denise Greco, Jakub Zlatohlavek, Shohag Bhargava, Iva Malatova and others.
Meghan Bliss-Moreau's phone number is N/A
See more information about Meghan Bliss-Moreau